Vitamin B12 is distributed into the milk of nursing women in concentrations that approximate the maternal blood vitamin B12 concentration
Triple-hormone-receptor agonist Retatrutide for obesity: Phase 2 trial (48-week study, up to 24% weight loss) American Diabetes Association (2023) ADA Press Release: Novel agent Retatrutide results in substantial weight reduction (83rd Scientific Sessions, Phase 2 data) ADA Meeting News (2023) Phase 2 trial results: benefits of Retatrutide in obesity, type 2 diabetes, NASH (83rd ADA Scientific Sessions coverage) ClinicalTrials.gov Study of Retatrutide (LY3437943) in adults with obesity (NCT04881760
Available In-Clinic & Mobile $279-$478 Electrolyte-rich hydration therapy that supports rapid recovery and endurance after workouts, travel, or fatigue
Molecular Characteristics Complete Specifications: Chemical Name: 5-Amino-1-methylquinolinium CAS Number: 42464-96-0 Molecular Weight: 159.21 Da (cation) Molecular Formula: CHN Structure: Quinolinium cation with amino group at position 5 Chemical Classification: Quinolinium compound, NNMT inhibitor Appearance: Yellow to yellow-orange powder Solubility: Water-soluble (charged cation), DMSO Target Enzyme: Nicotinamide N-methyltransferase (NNMT) Selectivity: Selective for NNMT vs
FDA policy places BPC-157 in Category 2 for 503A bulk substances, meaning FDA has identified safety concerns and does not intend to permit compounding under that interim policy
